Epilepsy Surgery in Sturge-weber-syndrome: Indications, Procedures and Outcomes at a Single Institution over 22 Years
Abstract number :
1.34
Submission category :
9. Surgery / 9B. Pediatrics
Year :
2022
Submission ID :
2204924
Source :
www.aesnet.org
Presentation date :
12/3/2022 12:00:00 PM
Published date :
Nov 22, 2022, 05:27 AM
Authors :
Michelle Chiu, MD, FRCPC – Boston Children's Hospital, Harvard Medical School; Masanori Takeoka, MD – Assistant Professor of Neurology, Boston Children's Hospital, Harvard Medical School; Scellig Stone, MD, PhD, FRCSC – Director of Epilepsy, Stereotactic and Functional Neurosurgery, Boston Children's Hospital, Harvard Medical School; Sanjay Prabhu, MBBS, DCH, MRCPCH, FRCR – Medical Director, Imaging Informatics, Boston Children's Hospital, Harvard Medical School; Joseph Madsen, MD – Director, Epilepsy Surgery, Boston Children's Hospital, Harvard Medical School; Anna Pinto, MD, PhD – Co-Director, Sturge Weber Clinic, Boston Children's Hospital, Harvard Medical School
Rationale: Sturge-Weber Syndrome (SWS) is a neurocutaneous disorder affecting the skin, brain and eyes. Its etiopathogenesis involves a somatic mosaic mutation in the GNAQ gene. Its classic triad consists of a port-wine stain in the trigeminal nerve distribution, leptomeningeal angiomatosis and glaucoma. Neurological manifestations include epileptic seizures, cognitive delay, hemiparesis and headaches. Epilepsy onset is prior to 1 year of age in 75% and seizures are medically refractory in 50%. Epilepsy surgery has been established as an effective treatment in patients with SWS. However, the timing and candidacy for epilepsy surgery remain controversial. There are few large-scale studies examining the indications, procedures and outcomes in children with SWS who undergo epilepsy surgery.
Methods: This retrospective cohort study includes all patients who meet the following criteria: (1) followed by an epileptologist at Boston Children’s Hospital, (2) clinical diagnosis of SWS, (3) underwent epilepsy surgery at BCH, (4) clinic visit between 01/2000 and 04/2022. Chart review of patient demographics, seizure history, EEG/imaging results, epilepsy surgery details and pathology findings was performed. Descriptive statistics and univariable logistic regression analysis were used.
Results: A total of 17 patients met the inclusion criteria, 14 with unilateral involvement and 3 with bilateral asymmetric involvement. Average seizure onset age was 7 m. Indication for epilepsy surgery was medically refractory epilepsy in all patients, including status epilepticus (n=12), seizure clusters (n=14), apnea/cyanosis (n=7) or secondarily generalized seizures (n=3). Most had pre-existing delays and 3 had regression. Eleven had hemispherectomies (7 anatomical, 4 functional), 6 had motor-sparing focal resection/disconnection. 3 required repeat surgery for incomplete disconnection. Average age at first surgery was 3 y; time between seizure onset and surgery ranged from 5 m to 10 y. Complications were reported after 4 operations (hemorrhage requiring evacuation, transient diabetes insipidus, incidental PICA infarction, delayed hydrocephalus). Pathology confirmed SWS in all specimens and cortical malformation in 7. Average follow-up time was 7 y with only 1 patient lost to follow-up. Engel class Ia seizure outcome was achieved in 11. 4 had class Ib outcome (3 hemispherectomies, 1 focal resection), one had class IIIa outcome (focal resection). Almost all had developmental stabilization or improvement. Of patients with dual pathology, 5/7 achieved class Ia outcome. Of patients with bilateral involvement, one had class Ia outcome and 2 had class Ib.
Conclusions: This retrospective cohort study examines trends and outcomes in surgical treatment of SWS patients at a large pediatric tertiary hospital over 22 years. There has been a shift towards less invasive surgeries; outcomes can be favorable with functional hemispherectomy and focal resections in carefully selected patients. Those with bilateral asymmetric involvement or dual pathology may also have favorable outcomes.
Funding: None
Surgery